[1] Bannai M, Ichikawa M, Nishihara M, et al. Effect of injection of antisense oligodeoxynucleotides of GAD isozymes into rat ventromedial hypothalamus on food intake and locomotor activity. Brain Res, 1998,784:305-315. [2] Wei J, Wu JY. Structural and functional analysis of cysteine residues in human glutamate decarboxylase 65 (GAD65) and GAD67. J Neurochem, 2005, 93(3):624-633. [3] B. S. Sukhareva, O. K. Mamaeva. Glutamate Decarboxylase: Computer Studies of Enzyme Evolution. Biochemistry, 2002,67:1180-1188. [4] Bu DF, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wagner-McPherson B, Evans GA & Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. PNAS 1992 89 2115–2119. [5] Schlosser M, Banga JP, Madec AM, et al. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes: Diabetologia, 2005,48(5):922-930. [6] Meyre D, Boutin P., and Tounian, et al. Is Glutamate Decarboxylase 2 (GAD2) a Genetic Link between Low Birth Weight and Subsequent Development of Obesity in Children?. J. Clin. Endocrinol. Metab, 2005,90:2384-2390. [7] Bu D F, A J. Tobin, The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD Genomics, 1994,21:222-228.
|